BioAdaptives, Inc. (BDPT)
OTCMKTS · Delayed Price · Currency is USD
0.0019
+0.0007 (55.74%)
Jul 27, 2026, 2:54 PM EST

BioAdaptives Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.020.020.010.030.020.02
Revenue Growth
3424.74%44.27%-55.65%66.31%-13.15%21.13%
Gross Profit
0.020.01-0.080.010.010.01
Operating Income
-0.99-1.04-0.58-0.23-0.42-0.64
Net Income
-1.47-1.56-0.9-0.71-0.9-1.05
Earnings Per Share
-0.14-0.15-0.11-0.12-1.27-4.67
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.070.160.140.060.030.08
Total Debt
0.460.380.490.330.390.44
Net Cash (Debt)
-0.38-0.23-0.36-0.27-0.37-0.35
Net Cash Growth
------
Net Cash Per Share
-0.04-0.02-0.04-0.04-0.52-1.57

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.5-0.52-0.25-0.22-0.23-0.16
Capital Expenditures
-0.02-0.02----
Free Cash Flow
-0.52-0.53-0.25-0.22-0.23-0.16
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
69.81%68.37%-37.88%41.49%51.10%
Operating Margin
-4166.29%-5701.79%-4610.39%-801.40%-2456.33%-3216.43%
Pretax Margin
-6186.31%-8523.35%-7097.33%-2494.19%-5214.08%-5309.20%
Profit Margin
-6186.31%-8523.35%-7097.33%-2494.19%-5214.08%-5309.20%
FCF Margin
-2189.64%-2921.68%-1969.51%-783.38%-1323.12%-802.24%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.6114.5238.9115.688.8225.69